Login / Register

Loading...

Advanced Search

List View Detail View

26-46 of 46 items

Product

Clone

Appl.

Reg

Cat#

Size

Price

Quantity
- TotalSeq™-B0151 anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  PG
  
  RUO
  
  369629
  
  10 µg
  
  £253
- TotalSeq™-C0151 anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  PG
  
  RUO
  
  369621
  
  10 µg
  
  £253
- TotalSeq™-D0151 anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  PG
  
  RUO
  
  369635
  
  10 µg
  
  £253
- Spark Red™ 718 anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369641
  
  25 tests
  
  £103
- 369642
  
  100 tests
  
  £213
- Brilliant Violet 421™ anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369605
  
  25 tests
  
  £130
- 369606
  
  100 tests
  
  £294
- Brilliant Violet 510™ anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369649
  
  25 tests
  
  £133
- 369650
  
  100 tests
  
  £279
- Brilliant Violet 785™ anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369623
  
  25 tests
  
  £136
- 369624
  
  100 tests
  
  £298
- Brilliant Violet™ 711 anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369631
  
  25 tests
  
  £136
- 369632
  
  100 tests
  
  £298
- Brilliant Violet 605™ anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369609
  
  25 tests
  
  £140
- 369610
  
  100 tests
  
  £298
- Brilliant Violet 650™ anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369647
  
  25 tests
  
  £152
- 369648
  
  100 tests
  
  £298
- Spark Blue™ 574 anti-human CD152 (CTLA-4) (Flexi-Fluor™) Antibody
  
  BNI3
  
  FC
  
  RUO
  
  285166
  
  50 µg
  
  £270
- Spark Blue™ 550 anti-human CD152 (CTLA-4) (Flexi-Fluor™) Antibody
  
  BNI3
  
  FC
  
  RUO
  
  285259
  
  50 µg
  
  £270
- PE/Dazzle™ 594 anti-human CD152 (CTLA-4) Antibody
  
  BNI3
  
  FC, ICFC
  
  RUO
  
  369615
  
  25 tests
  
  £109
- 369616
  
  100 tests
  
  £254

ProductsHere

Follow Us

Follow Us